Electromed (ELMD) Cash from Financing Activities (2010 - 2026)

Electromed's (ELMD) quarterly Cash from Financing Activities came in at -$128000.0 in Q1 2026, up 96.02% year-on-year from -$65298.7 in Q1 2025, and up 95.25% on a QoQ basis from -$2.7 million in Q4 2025.

Electromed (ELMD) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Electromed (ELMD) has 17 years of Cash from Financing Activities data on file, last reported at -$128000.0 in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 96.02% year-over-year to -$128000.0 in Q1 2026; TTM through Mar 2026 was -$7.5 million, a 9.09% increase from a year earlier, with the FY2025 full-year figure at -$11.9 million, down 33100.0% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$128000.0, up from -$2.7 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for ELMD reached as high as $56000.0 in Q1 2024 and fell as low as -$4.5 million in Q3 2024.
  • Historically, Cash from Financing Activities has averaged -$994823.5 across 5 years, with a median of -$221000.0 in 2023.
  • Across the five-year window, Cash from Financing Activities jumped 225.0% in 2023 and tumbled 15503.45% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at $8000.0 in 2022, then soared by 225.0% to $26000.0 in 2023, then tumbled by 2188.46% to -$543000.0 in 2024, then sank by 395.76% to -$2.7 million in 2025, then surged by 95.25% to -$128000.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$128000.0 in Q1 2026, -$2.7 million in Q4 2025, and -$1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Electromed 313.26 Mn 296.27 Mn 14.64 Mn -128,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -128,000.00
Mar 31, 2026 -128,000.00
Dec 31, 2025 -2.69 Mn
Dec 31, 2025 -2.69 Mn
Sep 30, 2025 -1.08 Mn
Sep 30, 2025 -1.08 Mn
Jun 30, 2025 -3.65 Mn
Jun 30, 2025 -3.65 Mn
Mar 31, 2025 -3.22 Mn
Mar 31, 2025 -3.22 Mn
Dec 31, 2024 -543,000.00
Dec 31, 2024 -543,000.00
Sep 30, 2024 -4.47 Mn
Sep 30, 2024 -4.47 Mn
Jun 30, 2024 -75,000.00
Jun 30, 2024 -75,000.00
Mar 31, 2024 56,000.00
Mar 31, 2024 56,000.00
Dec 31, 2023 26,000.00
Dec 31, 2023 26,000.00